However, many of these studies found liver fibrosis to be associated with other factors during drug therapy, including poor viral control, low CD4 T cell counts, presence of HCV infection, older age, and alcohol abuse [10, 12, 67, 68], which were not recapitulated in our SIV-macaque experiments. Here, CD4 is linked to Hepatic fibrosis.